8/104 sources · 2 publishersUpdated Oct 8, 16:55 UTC
Smith+Nephew begins European rollout of CARTIHEAL AGILI-C implant
Smith+Nephew has started commercial sales of its CARTIHEAL AGILI-C cartilage-repair implant in Europe, extending a product introduced in the United States in 2024. The aragonite-based implant is intended to support cartilage and bone repair for knee conditions. Smith+Nephew will present the product at the ICRS meeting in Porto, Portugal.
Why it matters
The launch opens additional European markets for Smith+Nephew's cartilage-repair portfolio. The company says it intends to extend availability beyond the initial markets.
Key facts
- 1Smith+Nephew announced that CARTIHEAL AGILI-C is commercially available in Europe. globenewswire.com
- 2The implant had been introduced in the United States during 2024. globenewswire.com
- 3The product is scheduled to be featured at the ICRS congress in Porto from 8 to 10 October. globenewswire.com
- 4A randomized multicenter trial found higher overall KOOS results for the implant than standard surgery through 60 months of follow-up. globenewswire.com
- 5Smith+Nephew said the initial European rollout covers specified markets and that further country launches are planned soon. globenewswire.com
Summary written by AlphAI from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.